Larimar Therapeutics, Inc. (NASDAQ:LRMR) was one of the stocks that was covered in that article. Wall Street analysts believe ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

CRISPR-edited iPSCs uncover early mitochondrial defects shared across ALS mutations, revealing pathways that could guide future treatments.

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

Sana Biotechnology, Inc.’s SANA share price has dipped by 5.61%, which has investors questioning if this is right time to buy ...

The company, which was founded in 2006, rose to prominence by offering at-home DNA testing kits that allowed people to ...

Supreme Court upholds lower court's decision that SK bioscience's PCV13 components do not fall within scope of Pfizer's patent claims - Anadolu Ajansı ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

Franklin Biotechnology Discovery Fund's Q1 2025 report covers market trends, key holdings, risks, and outlook—essential ...

Scientists at the McGovern Institute and the Broad Institute of MIT and Harvard have reengineered a compact RNA-guided enzyme ...

Stellenbosch University (SU) has announced the opening of the LaunchLab CERIBIO, a biotechnology laboratory for biotechnology ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.